Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study on NovoSeven® Room Temperature Stable (VII25) in Patients With Haemophilia A or B

NCT01220141 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01220141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study on NovoSeven® Room Temperature Stable (VII25) in Patients With Haemophilia A or B
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
March 31, 2015
Enrollment
51 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a, haemophilia b